Get started
Author

Yigang Guo

Observed name: YiGang Guo
Institution: Taihe Hospital
ORCID: 0009-0009-2836-8513
Observed ORCID: 0009-0009-2836-8513
OpenAlex ID: A5113660859
N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
2022 · Lulu Zhang, Wen Ke, et al. · Frontiers in Genetics · 12
Bioinspired medical indwelling catheters with hierarchically structured coatings exhibiting specific wettability and antibacterial property
2023 · Xuelian Feng, Yigang Guo, et al. · Colloids and Surfaces B Biointerfaces · 11
The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma
2023 · Yigang Guo, Xuelian Feng, et al. · Irish Journal of Medical Science (1971 -) · 3
Efficacy and safety of plasmapheresis without plasma transfusion tandem with chemotherapy to treat multiple myeloma
2022 · Yigang Guo, Lulu Zhang, et al. · Hematology · 2
Dual targeting of BCR::ABL1 and DNA methylation in advanced CML: A 3-year survival analysis of TKI-Azacitidine combination therapy
2026 · Zhuming Yang, Danlei Han, et al. · Therapeutic Advances in Hematology
Identification of Beclin-1 inhibitors to treat Immune thrombocytopenia by structure-based virtual screening and molecular modelling approaches
2025 · RuiBo Zhang, Juan Peng, et al. · Journal of King Saud University - Science
PDF
Comparison of viral nucleic acid test results of pharyngeal swabs versus induced sputum specimens in 33 patients with COVID-19 after treatment
2021 · Dongsheng Xu, W. Chen, et al. · Wuhan Daxue xuebao. Yixue ban
Works count: 7
Citation count: 28
H-index: 3
I10-index: 2
Year
Topic
Type